Trial Site Detail

 

Drug:
IPI-493
Trial:
A Phase I Dose Escation Study of IPI-493
Conditions: Solid Tumors
Trial Status:
Terminated

 

Mary Crowley Medical Research Center (Central Office)

     
Dallas , TX 75201
USA

 

Principal Investigator:
 Neil Senzer, MD
Contact:
 Kay Easterwood-Sanchez 214-658-1943
Activation Status of this Site:
 Active
Notes about this Site:
Mary Crowley Medical Research Center (Central Office) Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.